Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update: a Phase 1 study evaluating bladder perfusion with plasma-activated saline for bladder cancer; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plasma-Activated Saline (plasma-activated saline)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Bladder (Urothelial, Transitional Cell) Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING